Get Live Data

SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. B90 Holdings Share Price
  4. B90 Holdings Share Regulatory News
  5. Suspension - Velox3 Plc

Pin to quick picksB90 Holdings Regulatory News (B90)

B90 Holdings Information

Share Price Information for B90 Holdings (B90)

Share Price is delayed by 15 minutes
Get Live Data
2.40    0.00 (0.00%)
Bid:
2.20
Ask:
2.60
Spread: 0.40 (18.182%)
Market Cap: £10.58m
B90 Live PriceLast checked at - London Stock Exchange

Intraday B90 Holdings Share Chart

Suspension - Velox3 Plc

7 Dec 2015 07:30

RNS Number : 0841I
AIM
07 December 2015
 

 

 

 

NOTICE

 

07/12/2015 7:30am

 

TEMPORARY SUSPENSION OF TRADING ON AIM

 

VELOX3 PLC

 

Trading on AIM for the under-mentioned securities has been temporarily suspended from 07/12/2015 7:30am, pursuant to AIM Rule 15.

 

ORDINARY SHARES OF NO PAR VALUE, FULLY PAID (BBJPL87) (IM00BBJPL870)

 

If you have any queries relating to the above, please contact the company's nominated adviser on 020 7601 6100.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EXCBSBDDUGGBGUS
123456
Date   Source Headline
6th May 20267:00 amRNSFinal Results
27th Apr 20267:00 amRNSNotice of Final Results
9th Feb 20267:00 amRNSBoard Change
2nd Feb 20267:00 amRNSTrading Update
28th Nov 20257:00 amRNSStatement re: UK Budget
22nd Sep 20257:00 amRNSInterim Results
18th Sep 20257:00 amRNSNotice of Investor Presentation
16th Sep 20259:44 amRNSResult of AGM and Notice of Interim Results
29th Aug 20257:00 amRNSNotice of AGM
22nd Jul 20257:00 amRNSTrading Update
30th Jun 20257:00 amRNSGrant of Options
12th Jun 202510:33 amRNSDirector Dealings
12th May 20257:00 amRNSOnline Investor Presentation
7th May 20257:00 amRNSFinal Results
4th Feb 20257:00 amRNSTrading Update
12th Dec 20247:00 amRNSDirector's Exercise of Options
23rd Sep 20247:00 amRNSInterim Results
17th Sep 202410:37 amRNSResult of AGM and Notice of Interim Results
30th Aug 20247:00 amRNSNotice of AGM
27th Aug 20244:00 pmRNSTR-1
9th Aug 20249:46 amRNSTR-1
5th Aug 20249:53 amRNSDirector’s purchase of shares
30th Jul 20247:00 amRNSTrading Update
17th Jun 20242:22 pmRNSDirector/PDMR Shareholding
11th Jun 20244:19 pmRNSDirector’s purchase of shares
21st May 20247:00 amRNSOddsen.nu marketing agreements
16th May 20247:00 amRNSFinal Results
18th Apr 20247:00 amRNSOddsen.nu goes global
25th Mar 20247:00 amRNSTR-1
25th Mar 20247:00 amRNSTR-1
5th Mar 20247:00 amRNSDirector Dealings
1st Mar 20247:00 amRNSTR-1
1st Feb 20247:00 amRNSTrading Update
22nd Jan 20242:30 pmRNSDirector Dealings
8th Nov 20237:00 amRNSShift to B2B Operations: Relaunch of Bet90.com
30th Oct 20237:00 amRNSGrant of Options
28th Sep 20237:00 amRNSUnaudited Interim Results
15th Sep 20237:00 amRNSPlacing and Subscription, Conversion of CLNs
14th Aug 20237:00 amRNSAppointments: NED; Chief Finance, M&A Dev. Officer
31st Jul 20233:14 pmRNSResult of AGM
17th Jul 202311:28 amRNSPosting of AGM Notice
13th Jul 20237:00 amRNSFURTHER RE SUBSCRIPTION
12th Jul 20237:00 amRNSAcquisition of Emwys; Licence Agreement; CLN issue
30th Jun 20237:01 amRNSFundraising and Board Changes
30th Jun 20237:00 amRNSFinal Results
6th Jun 20237:00 amRNSAppointment of New Broker
28th Apr 20235:02 pmRNSDirector’s purchase of shares
21st Apr 20231:21 pmRNSDirector’s purchase of shares
19th Apr 20237:00 amRNSGrant of Options
5th Apr 20232:10 pmRNSRaise of a further £1.1 million
123456

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
CCP
Celtic
LSE
0.00%
JEGI
Jpmorgan Euro.
LSE
2.09%
JGGI
JPMorgan Global Growth & Income
LSE
1.62%
ROR
Rotork
LSE
0.66%
SVST
SVST.L
LSE
0.00%
Trending
IMM
Immupharma
LSE
5.42%
AVCT
Avacta Group
LSE
3.65%
PREM
Premier African Minerals
LSE
4.88%
SBTX
Skinbiotherap.
LSE
30.77%
CPX
CAP-XX
LSE
-1.82%